The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Insmed Incorporated (INSM) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.84, or -4.16%, to $19.33. The Insmed Incorporated has recorded 110,305 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Insmed to Host Investor and Analyst Event on May 8, 2023.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Insmed Incorporated is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $20.17 and fluctuated between $20.23 as its day high and $19.40 as its day low. The current market capitalization of Insmed Incorporated is $2.72B. A total of 1.08 million shares were traded on the day, compared to an average of 1.19M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, INSM has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 3,798 shares. Over the last 12 months, there were 33 BUYs and 34 SELLs from insiders. Insiders purchased 772,917 shares during that period but sold 395,397.
In the most recent transaction, Lewis William sold 6,994 shares of INSM for 18.00 per share on Jan 10. After the transaction, the Chair and CEO now owns 265,067 company shares. In a previous transaction on Jan 10, Flammer Martina M.D. sold 3,439 shares at 18.06 per share. INSM shares that Chief Medical Officer owns now total 72,763.
Among the insiders who sold shares, Adsett Roger disposed of 3,194 shares on Jan 10 at a per-share price of $17.99. This resulted in the Chief Operating Officer holding 135,487 shares of INSM after the transaction. In another insider transaction, Bonstein Sara sold 2,857 shares at $18.12 per share on Jan 10. Company shares held by the Chief Financial Officer now total 66,031.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for INSM in the last 3 months, the mean price target is $39.54 with high estimates of $52.00 and low estimates of $28.00. In terms of 52-week highs and lows, INSM has a high of $28.94 and a low of $16.04.
As of this writing, INSM has an earnings estimate of -$1.11 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.88 per share and a lower estimate of -$1.26. The company reported an EPS of -$1.09 in the last quarter, which was -22.50% lower than expectations of -$0.89.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. INSM’s latest balance sheet shows that the firm has $716.78M in Cash & Short Term Investments as of fiscal 2021. There were $612.27M in debt and $135.17M in liabilities at the time. Its Book Value Per Share was $0.66, while its Total Shareholder’s Equity was $410.47M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 13 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INSM is Hold with a score of 5.00. A total of 12 analysts rated the stock as Buy while 1 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.